ANDA 83173, held by Intl Medication. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 83173 (Lidocaine Hydrochloride), held by Intl Medication, was first approved by FDA on Sep 17, 1975, with 24 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Lidocaine Hydrochloride Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 17, 1975 | Original application | Approved | None posted |
| Lidocaine Hydrochloride1% · injectable;injection | Lidocaine Hydrochloride | RxReference drug |
| Lidocaine Hydrochloride2% · injectable;injection | Lidocaine Hydrochloride | Rx |
| Apr 21, 2021 | Supplement 45Labeling · Standard review | Approved | None posted |
| Sep 1, 2005 | Supplement 36Labeling | Approved | None posted |
| Sep 19, 2002 | Supplement 37Manufacturing | Approved | None posted |
| Apr 6, 2001 | Supplement 34Labeling | Approved | None posted |
| Jan 14, 1998 | Supplement 30Manufacturing | Approved | None posted |
| Sep 19, 1995 | Supplement 33Manufacturing | Approved | None posted |
| Jun 17, 1994 | Supplement 32Manufacturing | Approved | None posted |
| Jun 1, 1994 | Supplement 31Manufacturing | Approved | None posted |
| Oct 29, 1993 | Supplement 29Manufacturing | Approved | None posted |
| Oct 19, 1993 | Supplement 14Labeling | Approved | None posted |
| Jul 8, 1993 | Supplement 26Labeling | Approved | None posted |
| Jul 8, 1993 | Supplement 25Manufacturing | Approved | None posted |
| Apr 30, 1993 | Supplement 28Labeling | Approved | None posted |
| Feb 8, 1993 | Supplement 24Manufacturing | Approved | None posted |
| Dec 23, 1992 | Supplement 19Manufacturing | Approved | None posted |
| Dec 23, 1992 | Supplement 18Labeling | Approved | None posted |
| Dec 17, 1992 | Supplement 27Manufacturing | Approved | None posted |
| Oct 27, 1992 | Supplement 22Manufacturing | Approved | None posted |
| Nov 26, 1991 | Supplement 20Manufacturing | Approved | None posted |
| Jun 20, 1991 | Supplement 21Labeling | Approved | None posted |
| Jul 10, 1987 | Supplement 13Manufacturing | Approved | None posted |
| Jun 16, 1987 | Supplement 10Manufacturing | Approved | None posted |
| May 16, 1986 | Supplement 7Manufacturing | Approved | None posted |
| Mar 11, 1986 | Supplement 8Manufacturing | Approved | None posted |
| Sep 17, 1975 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters